hnRNP A1 , hnRNP A2B1 , and hnRNP K are dysregulated in tauopathies, but do not colocalize with tau pathology
Brain Pathology · 2025
DOI: 10.1111/bpa.13305 ↗Kurz gefasst
Fachartikel in der Zeitschrift Brain Pathology, 2025. Verfasst von Tomas Kavanagh und 6 weiteren Autor:innen. Beteiligte Einrichtung: Brain and Mind Centre and School of Medical Sciences, University of Sydney, Camperdown, New South Wales, Australia. Hauptthemen laut MEDLINE: tau Proteins, Tauopathies, Heterogeneous-Nuclear Ribonucleoprotein K, Heterogeneous Nuclear Ribonucleoprotein A1. Die Arbeit wurde bisher 17-mal zitiert (Crossref) und nennt 42 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: The University of Sydney, Bluesand Foundation, NIA NIH HHS.
Abstract (Originalsprache)
Tau interacts with multiple heterogeneous nuclear ribonucleoproteins (hnRNPs)—a family of RNA binding proteins that regulate multiple known cellular functions, including mRNA splicing, mRNA transport, and translation regulation. We have previously demonstrated particularly significant interactions between phosphorylated tau and three hnRNPs (hnRNP A1, hnRNP A2B1, and hnRNP K). Although multiple hnRNPs have been previously implicated in tauopathies, knowledge of whether these hnRNPs colocalize with tau aggregates or show cellular mislocalization in disease is limited. Here, we performed a neuropathological study examining the colocalization between hnRNP A1, hnRNP A2B1, hnRNP K, and phosphorylated tau in two brain regions (hippocampus and frontal cortex) in six disease groups (Alzheimer's disease, mild cognitive impairment, progressive supranuclear palsy, corticobasal degeneration, Pick's disease, and controls). Contrary to expectations, hnRNP A1, hnRNP A2B1, and hnRNP K did not colocalize with AT8‐immunoreactive phosphorylated tau pathology in any of the tauopathies examined. However, we did observe significant cellular mislocalization of hnRNP A1, hnRNP A2B1 and hnRNP K in tauopathies, with unique patterns of mislocalization observed for each hnRNP. These data point to broad dysregulation of hnRNP A1, A2B1 and K across tauopathies with implications for disease processes and RNA regulation.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Brain and Mind Centre and School of Medical Sciences, University of Sydney, Camperdown, New South Wales, Australia.
- Center for Cognitive Neurology and Departments of Neurology, Pathology and Psychiatry, Grossman School of Medicine, New York University, New York, New York, USA.
ORCID-Profile: Eleanor Drummond
Förderung
- The University of Sydney
- Bluesand Foundation
- NIA NIH HHS
- TDM Foundation
- Alzheimer's Association
- Faculty of Medicine and Health, University of Sydney
- NIH HHS
- National Health and Medical Research Council
Zitieren
APA
Kavanagh, T., Balcomb, K., Ahmadi Rastegar, D., Lourenco, G. F., Wisniewski, T., Halliday, G., & Drummond, E. (2025). hnRNP A1 , hnRNP A2B1 , and hnRNP K are dysregulated in tauopathies, but do not colocalize with tau pathology. Brain Pathology. https://doi.org/10.1111/bpa.13305
Vancouver
Kavanagh T, Balcomb K, Ahmadi Rastegar D, Lourenco GF, Wisniewski T, Halliday G, et al. hnRNP A1 , hnRNP A2B1 , and hnRNP K are dysregulated in tauopathies, but do not colocalize with tau pathology. Brain Pathology. 2025. doi:10.1111/bpa.13305
BibTeX
@article{Kavanagh2025,
author = {Kavanagh, Tomas and Balcomb, Kaleah and Ahmadi Rastegar, Diba and Lourenco, Guinevere F and Wisniewski, Thomas and Halliday, Glenda and Drummond, Eleanor},
title = {hnRNP A1 , hnRNP A2B1 , and hnRNP K are dysregulated in tauopathies, but do not colocalize with tau pathology},
journal = {Brain Pathology},
year = {2025},
doi = {10.1111/bpa.13305}
}
EUVIMED